These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Looking beyond death: a morphogenetic role for the TNF signalling pathway. Mathew SJ; Haubert D; Krönke M; Leptin M J Cell Sci; 2009 Jun; 122(Pt 12):1939-46. PubMed ID: 19494121 [TBL] [Abstract][Full Text] [Related]
3. TRAIL and apoptosis induction by TNF-family death receptors. Wang S; El-Deiry WS Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624 [TBL] [Abstract][Full Text] [Related]
4. Messengers of cell death: apoptotic signaling in health and disease. Rossi D; Gaidano G Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419 [TBL] [Abstract][Full Text] [Related]
6. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X; Kandasamy K; Srivastava RK Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723 [TBL] [Abstract][Full Text] [Related]
7. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. Rowinsky EK J Clin Oncol; 2005 Dec; 23(36):9394-407. PubMed ID: 16361639 [TBL] [Abstract][Full Text] [Related]
8. Targeting death receptors in cancer with Apo2L/TRAIL. Kelley SK; Ashkenazi A Curr Opin Pharmacol; 2004 Aug; 4(4):333-9. PubMed ID: 15251125 [TBL] [Abstract][Full Text] [Related]
9. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge]. Belka C; Betsch A; Marini P; Jendrossek V; Bamberg M; Budach W Strahlenther Onkol; 2003 Mar; 179(3):141-51. PubMed ID: 12627256 [TBL] [Abstract][Full Text] [Related]
10. [Current concepts on apoptotic signalling pathways: new targets for anticancer strategies]. Ségal-Bendirdjian E; Hillion J; Belmokhtar CA Bull Cancer; 2003 Jan; 90(1):9-17. PubMed ID: 12609799 [TBL] [Abstract][Full Text] [Related]
11. Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Liao X; Wang X; Gu Y; Chen Q; Chen LY Life Sci; 2005 May; 77(2):160-74. PubMed ID: 15862601 [TBL] [Abstract][Full Text] [Related]
12. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Ashkenazi A Nat Rev Cancer; 2002 Jun; 2(6):420-30. PubMed ID: 12189384 [No Abstract] [Full Text] [Related]
13. 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. LaVallee TM; Zhan XH; Johnson MS; Herbstritt CJ; Swartz G; Williams MS; Hembrough WA; Green SJ; Pribluda VS Cancer Res; 2003 Jan; 63(2):468-75. PubMed ID: 12543804 [TBL] [Abstract][Full Text] [Related]
14. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy. Younes A; Kadin ME J Clin Oncol; 2003 Sep; 21(18):3526-34. PubMed ID: 12972530 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor and trail interactions in epithelial-derived cells. Gibson SB Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179 [TBL] [Abstract][Full Text] [Related]
16. Signaling through death receptors in cancer therapy. Fulda S; Debatin KM Curr Opin Pharmacol; 2004 Aug; 4(4):327-32. PubMed ID: 15251124 [TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Nakata S; Yoshida T; Horinaka M; Shiraishi T; Wakada M; Sakai T Oncogene; 2004 Aug; 23(37):6261-71. PubMed ID: 15208660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]